Document is current
Any future updates will be listed below
-
Authors
Gjerulfsen, Cathrine E. https://orcid.org/0000-0002-3419-3133
Juhl, Stefan
Mieszczanek, Katarzyna M.
Spanilá, Lucie
Thygesen, Kristin S.
Pavbro, Agnieszka
Møller, Rikke S. https://orcid.org/0000-0002-9664-1448
Rubboli, Guido https://orcid.org/0000-0002-5309-2514
-
Funding
Funding for this research was provided by:
Copenhagen University
- License Information
-
More Information
Article History
Received: 13 December 2024
Accepted: 6 April 2025
First Online: 15 April 2025
Declarations
:
: Informed consent was obtained from all individual participants included in the study.
: Ethical approval was waived by the local Ethics Committee of The Danish Epilepsy Center, Filadelfia, Dianalund, Denmark, in view of the retrospective nature of the study and all the procedures being performed were part of the routine care.
: GR has received speaker fees from Angelini Pharma and UCB Pharma and participated to advisory boards meetings of Angelini Pharma and UCB Pharma. RSM has received consulting fees from UCB Pharma, Orion, Saniona, and Immedica, and speaker fees from EISAI, Angelini Pharma, Jazz Pharmaceuticals, Orion, and UCB Pharma. CEG has received funding for research and speaker honoraria from UCB Pharma.None of the authors has recent, present, or anticipated employment by any organization that may gain or lose financially through the publication of the manuscript, nor any financial or non-financial interests to disclose.
